Evidence map›Paper›PMID 41705041›Full record

ArticleNeurology. Clinical practice2026

Assessing the Relationship of Quality of Life With Functional Status in a Large Cohort of Adult Patients With Neuromuscular Disorders.

Karen S W Wong, Anando Sen, Jassi Michell-Sodhi, Dionne Moat, Michelle McCallum, Mark Richardson, Elizabeth Harris, Anna G Mayhew, Michela Guglieri, Emma Grover and 9 more

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Karen S W WongJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0009-0000-1928-0469
Anando SenJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0001-6761-2632
Jassi Michell-SodhiJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0009-0000-3877-3824
Dionne MoatJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0009-0000-9829-7647
Michelle McCallumJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0009-0003-5427-8905
Mark RichardsonJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0003-3431-916X
Elizabeth HarrisJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0002-4489-3977
Anna G MayhewJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0001-7085-9011
Michela GuglieriJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0002-8455-0637
Emma GroverJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0009-0008-7689-086X
Jordi Diaz-ManeraJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0003-2941-7988
Emma RobinsonJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0002-6221-4691
Maha ElseedJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0003-2739-2668
Joseph MasonJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0009-0007-6783-317X
Chloe GeaganJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0009-0007-5393-8456
Meredith K JamesJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0001-8078-7744
Volker StraubJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0001-9046-3540
Chiara Marini-BettoloJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0003-3795-6017
Robert Muni-LofraJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.ORCID 0000-0002-8901-9140

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Health-related quality of life (HR-QoL) is compromised in patients with neuromuscular disorders (NMDs). Disease severity alone does not predict HR-QoL; there are other known predictors including physical, psychological, and social factors. This study aims to provide insight into how mobility, age, and diagnosis may affect HR-QoL in adults with NMD. Methods: The QoL in Genetic Neuromuscular Disease Questionnaire (QoL-gNMD) was completed by adult patients with NMDs before attending a clinical visit at the John Walton Muscular Dystrophy Research Centre in Newcastle upon Tyne, UK. The Summary of Function Scale was administered during the clinical visit to characterize mobility status. Results: A total of 580 responses were included in this cross-sectional study. Overall perceived health and HR-QoL were reported poorest by ambulant patients who walked using aids. Items from the QoL-gNMD that were affected the most by NMDs were future planning and the need to rely more on others. A nonlinear trend where patients with "midlevel" mobility (walked with aids or manual wheelchair users) reported the poorest HR-QoL were observed in all 3 HR-QoL domains: Impact of Physical Symptoms (IPSs), Self-Perception (SP), and Activities and Social Participation (ASP). This nonlinear trend between HR-QoL and mobility was observed for younger patients but became more linear in older age groups. In our cohort, patients with "midlevel" mobility were the oldest, and those with the lowest levels of mobility (i.e., powered wheelchair users) were the youngest. Interaction between age and mobility was significant and both affected HR-QoL. There was marked variability in HR-QoL between diagnoses. Diagnosis was a significant factor for IPS ( Discussion: Age and mobility status affect HR-QoL. Individuals with limited ambulation reported the poorest HR-QoL, which was partially restored in powered wheelchair users, to levels comparable with more ambulant patients. However, the positive effect of wheelchair use became less substantial as patients get older. There was also marked variability in HR-QoL between diagnoses that was unrelated to physical disability. These findings provide evidence to guide care management discussions and highlight the importance of timely introduction of powered mobility.

Identifiers

PMID41705041
PMCPMC12908905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.